Location History:
- El Dorado Hills, CA (US) (2019 - 2021)
- San Jose, CA (US) (2024)
Company Filing History:
Years Active: 2019-2025
Title: Hédia Maamar: Innovator in Molecular Diagnostics
Introduction
Hédia Maamar is a prominent inventor based in El Dorado Hills, CA (US). She has made significant contributions to the field of molecular diagnostics, holding a total of 8 patents. Her work focuses on developing innovative diagnostic systems that enhance the detection of various diseases.
Latest Patents
One of Hédia Maamar's latest patents is a diagnostic system that provides methods and systems for point-of-care nucleic acid amplification and detection. This system includes a cartridge and an instrument designed to facilitate various sample processing steps for molecular diagnostic tests. The cartridge can accept biological samples, such as urine or blood, and comprises modules for loading, lysis, purification, and amplification.
Another notable patent involves polynucleotides for the amplification and detection of SARS-CoV-2. This patent discloses primers and probes that are essential for detecting SARS-CoV-2 through nucleic acid amplification testing (NAAT). The technology aims to amplify and determine the presence of the virus in test samples, aiding in the diagnosis of Covid-19.
Career Highlights
Hédia Maamar is currently associated with Talis Biomedical Corporation, where she continues to innovate in the field of diagnostics. Her expertise and dedication have positioned her as a key player in advancing molecular diagnostic technologies.
Collaborations
Hédia collaborates with talented individuals such as Sayeed Andeshmand and Thomas Henry Cauley, III. These partnerships enhance her research and development efforts, contributing to the success of her projects.
Conclusion
Hédia Maamar's work in molecular diagnostics exemplifies her commitment to innovation and improving healthcare outcomes. Her patents reflect her expertise and the impact of her contributions to the field.